Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
PagSeguro Digital
PAGS
$2.45B
| $1.27M | ﹤0.01% |
134,830
-5,136,287
| -97% | -$52.1M |
|
3777
Village Super Market
VLGEA
$652M
| $1.27M | ﹤0.01% |
55,717
+15,201
| +38% | +$330K |
|
3778
Kymera Therapeutics
KYMR
$9.82B
| $1.27M | ﹤0.01% |
+55,201
| New | +$1.58M |
|
3779
Usana Health Sciences
USNA
$259M
| $1.27M | ﹤0.01% |
20,130
+11,928
| +145% | +$760K |
|
3780
Sportradar
SRAD
$3.83B
| $1.27M | ﹤0.01% |
98,312
-244,212
| -71% | -$2.94M |
|
|
EPIX
3781
DELISTED
ESSA Pharma
EPIX
| $1.27M | ﹤0.01% |
469,002
+49,935
| +12% | +$146K |
|
3782
PUT
Everest Group
EG
$14.5B
| $1.26M | ﹤0.01% |
+3,700
| New | +$1.34M |
|
3783
Vroom Inc
VRM
$48.1M
| $1.26M | ﹤0.01% |
10,976
+8,407
| +327% | +$641K |
|
|
VAPO
3784
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $1.26M | ﹤0.01% |
354,355
-14,395
| -4% | -$66K |
|
3785
CALL
SoFi Technologies
SOFI
$23.3B
| $1.26M | ﹤0.01% |
151,200
+8,000
| +6% | +$52.2K |
|
|
MREO
3786
Mereo BioPharma
MREO
$40.3M
| $1.26M | ﹤0.01% |
955,071
-1,550,559
| -62% | -$1.8M |
|
|
MDRX
3787
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.26M | ﹤0.01% |
+100,000
| New | +$1.21M |
|
|
VISN
3788
Vistance Networks Inc
VISN
$1.4B
| $1.26M | ﹤0.01% |
223,088
-1,749,680
| -89% | -$8.36M |
|
|
GATO
3789
DELISTED
Gatos Silver, Inc.
GATO
| $1.26M | ﹤0.01% |
332,268
+49,548
| +18% | +$267K |
|
|
CCF
3790
DELISTED
Chase Corporation
CCF
| $1.26M | ﹤0.01% |
+10,356
| New | +$1.19M |
|
|
CALB
3791
DELISTED
California BanCorp Common Stock
CALB
| $1.26M | ﹤0.01% |
83,690
-20,240
| -19% | -$315K |
|
3792
Select Water Solutions
WTTR
$2.49B
| $1.25M | ﹤0.01% |
154,617
-208,406
| -57% | -$1.58M |
|
3793
CALL
Manulife Financial
MFC
$70.9B
| $1.25M | ﹤0.01% |
50,000
-250,000
| -83% | -$4.77M |
|
3794
Nuveen Multi-Asset Income Fund
NMAI
$481M
| $1.25M | ﹤0.01% |
+107,291
| New | +$1.24M |
|
3795
PUT
Cloudflare
NET
$107B
| $1.25M | ﹤0.01% |
19,100
+14,300
| +298% | +$853K |
|
3796
CALL
Incyte
INCY
$25.2B
| $1.25M | ﹤0.01% |
+20,000
| New | +$1.34M |
|
3797
iShares MSCI Peru and Global Exposure ETF
EPU
$568M
| $1.24M | ﹤0.01% |
40,601
-30,115
| -43% | -$924K |
|
3798
On Holding
ONON
$9.64B
| $1.24M | ﹤0.01% |
37,683
-954,775
| -96% | -$29M |
|
|
DCH
3799
PUT
Dauch Corp
DCH
$1.5B
| $1.24M | ﹤0.01% |
150,200
-300
| -0.2% | -$2.22K |
|
|
SPRB
3800
Spruce Biosciences
SPRB
$175M
| $1.24M | ﹤0.01% |
7,702
-416
| -5% | -$69.6K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.